BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 20, 2017
View Archived Issues
Denovo Biopharma will evaluate enzastaurin in biomarker-guided phase III study
Read More
Lucinactant shows favorable activity against bird flu in preclinical proof-of-concept study
Read More
Sobi adds rFIXFc-XTEN to its collaboration agreement with Bioverativ
Read More
Phase III SUNBEAM trial of oral ozanimod in patients with RMS meets primary endpoint
Read More
HSR clearance for collaboration and license agreement between Momenta and CSL
Read More
Oxidized form of membrane-bound vimentin as novel noninvasive biomarker of senescence
Read More
Small molecule UPC-K-005 acts through a novel inhibitory allosteric site in p38alpha
Read More
OlympiAD study supports utility of Myriad's BRACAnalysis CDx test in breast cancer
Read More
Takeda completes acquisition of Ariad Pharmaceuticals
Read More
Clinical data show malaria vaccine candidate PfSPZ-CVac is safe and efficacious
Read More
METIV-HCC phase III trial of tivantinib in HCC fails to meet primary endpoint
Read More
Toyama Chemical, Fujifilm identify novel C-X-C motif chemokine 10 inhibitors
Read More
Progenra describes new USP7/USP47 inhibitors
Read More
Immune Pharmaceuticals plans pivotal study of Ceplene in AML to support U.S. approval
Read More
Shire reflects on progress during fourth quarter of 2016
Read More
Grants supports work at University of Florida on improved Zika diagnostics
Read More
Kalytera Therapeutics completes acquisition of Talent Biotechs
Read More
Faron initiates phase II trial of Traumakine in patients with RAAA
Read More
EGFR(V)-EDV-dox nanocells carrying doxorubicin receives FDA orphan drug designation
Read More
Modus Therapeutics completes financing to support phase II trial of sevuparin
Read More
Autologous adipose-derived stromal vascular fraction cells studied in patients with Crohn's fistulas
Read More
EMA accepts Mereo's BPS-804 for Adaptive Pathways program
Read More
MIR17 family found to be a promising target for treating polycystic kidney disease
Read More
AstraZeneca licenses Zoladex commercial rights to TerSera in U.S. and Canada
Read More